Global News Anchor Katie Couric examines the experimental drug that could hold the key to help treat women with low libido. Sprout Pharmaceuticals is resubmitting its "pink pill" to the Food and Drug Administration for approval. The review process could take up to six months.
No comments:
Post a Comment
Through this ever open gate
None come too early
None too late
Thanks for dropping in ... the PICs